Clinical Trials Browser

Phase 2/3 × Lenograstim × Clear all

NCT01907009 2023-04-19

MEL-CAP

Phase 2/3 Terminated

Castrate Resistant Prostate Cancer

NCT01085058 2010-03-11

CU01

Phase 2/3 Completed

LymphoidPlasma cell

Hodgkin Disease, Multiple Myeloma